BFC Planning’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
BFC Planning's GMAB Position: Q3 2026 in Review
BFC Planning reduced its Genmab (GMAB) stake by 97% in Q3 2026, selling an estimated $16.8K and leaving 18 shares worth $642. The position accounts for ﹤0.01% of the portfolio, ranked #3252.
BFC Planning first reported a position in GMAB in Q3 2025 and has held it in 5 quarters since. The position peaked at $573K in Q1 2026. 258 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- BFC Planning held 18 shares of Genmab worth $642 as of Q3 2026.
- BFC Planning sold 530 Genmab shares in Q3 2026, an estimated $16.8K.
- Genmab made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3252 holding.
- BFC Planning first reported a position in Genmab in Q3 2025 and has held it in 5 quarters since.
- BFC Planning's Genmab position peaked at $573K in Q1 2026.
- 258 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.